These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 36436735

  • 1. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?
    Rajabi N, Mohammadnejad F, Doustvandi MA, Shadbad MA, Amini M, Tajalli H, Mokhtarzadeh A, Baghbani E, Silvestris N, Baradaran B.
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103212. PubMed ID: 36436735
    [Abstract] [Full Text] [Related]

  • 2. Photodynamic Therapy with Zinc Phthalocyanine Inhibits the Stemness and Development of Colorectal Cancer: Time to Overcome the Challenging Barriers?
    Gholizadeh M, Doustvandi MA, Mohammadnejad F, Shadbad MA, Tajalli H, Brunetti O, Argentiero A, Silvestris N, Baradaran B.
    Molecules; 2021 Nov 15; 26(22):. PubMed ID: 34833970
    [Abstract] [Full Text] [Related]

  • 3. Photodynamic therapy using zinc phthalocyanine with low dose of diode laser combined with doxorubicin is a synergistic combination therapy for human SK-MEL-3 melanoma cells.
    Doustvandi MA, Mohammadnejad F, Mansoori B, Tajalli H, Mohammadi A, Mokhtarzadeh A, Baghbani E, Khaze V, Hajiasgharzadeh K, Moghaddam MM, Hamblin MR, Baradaran B.
    Photodiagnosis Photodyn Ther; 2019 Dec 15; 28():88-97. PubMed ID: 31454716
    [Abstract] [Full Text] [Related]

  • 4. The therapeutic efficacy of 5-ALA based photodynamic therapy and chemotherapy combination in triple negative breast cancer cells.
    Erk B, Kamanli AF, Guney Eskiler G.
    Lasers Med Sci; 2024 Jul 23; 39(1):191. PubMed ID: 39043901
    [Abstract] [Full Text] [Related]

  • 5. The interaction between the light source dose and caspase-dependent and -independent apoptosis in human SK-MEL-3 skin cancer cells following photodynamic therapy with zinc phthalocyanine: A comparative study.
    Doustvandi MA, Mohammadnejad F, Mansoori B, Mohammadi A, Navaeipour F, Baradaran B, Tajalli H.
    J Photochem Photobiol B; 2017 Nov 23; 176():62-68. PubMed ID: 28964887
    [Abstract] [Full Text] [Related]

  • 6. A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer.
    Sambi M, Samuel V, Qorri B, Haq S, Burov SV, Markvicheva E, Harless W, Szewczuk MR.
    Drug Des Devel Ther; 2020 Nov 23; 14():1995-2019. PubMed ID: 32546966
    [Abstract] [Full Text] [Related]

  • 7. In silico analysis of the association of hsa-miR-16 expression and cell survival in MDA-MB-231 breast cancer cells subjected to photodynamic therapy.
    Cupido-Sánchez MG, Herrera-González NE, Mendoza CCB, Hernández MLM, Ramón-Gallegos E.
    Photodiagnosis Photodyn Ther; 2021 Mar 23; 33():102106. PubMed ID: 33217568
    [Abstract] [Full Text] [Related]

  • 8. Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.
    Dias LM, Sharifi F, de Keijzer MJ, Mesquita B, Desclos E, Kochan JA, de Klerk DJ, Ernst D, de Haan LR, Franchi LP, van Wijk AC, Scutigliani EM, Cavaco JEB, Tedesco AC, Huang X, Pan W, Ding B, Krawczyk PM, Heger M, Photodynamic Therapy Study Group.
    J Photochem Photobiol B; 2021 Mar 23; 216():112146. PubMed ID: 33601256
    [Abstract] [Full Text] [Related]

  • 9. Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity.
    Toubia I, Nguyen C, Diring S, Onofre M, Daurat M, Gauthier C, Gary-Bobo M, Kobeissi M, Odobel F.
    Org Biomol Chem; 2023 Aug 16; 21(32):6509-6523. PubMed ID: 37341568
    [Abstract] [Full Text] [Related]

  • 10. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
    Kuzyniak W, Ermilov EA, Atilla D, Gürek AG, Nitzsche B, Derkow K, Hoffmann B, Steinemann G, Ahsen V, Höpfner M.
    Photodiagnosis Photodyn Ther; 2016 Mar 16; 13():148-157. PubMed ID: 26162500
    [Abstract] [Full Text] [Related]

  • 11. Anti-Psoriasis Effects and Mechanisms of Α-(8-Quinolinoxy) Zinc Phthalocyanine-Mediated Photodynamic Therapy.
    Liu HQ, Wang YM, Li WF, Li C, Jiang ZH, Bao J, Wei JF, Jin HT, Wang AP.
    Cell Physiol Biochem; 2017 Mar 16; 44(1):200-214. PubMed ID: 29131032
    [Abstract] [Full Text] [Related]

  • 12. Novel zinc phthalocyanine as a promising photosensitizer for photodynamic treatment of esophageal cancer.
    Kuzyniak W, Schmidt J, Glac W, Berkholz J, Steinemann G, Hoffmann B, Ermilov EA, Gürek AG, Ahsen V, Nitzsche B, Höpfner M.
    Int J Oncol; 2017 Mar 16; 50(3):953-963. PubMed ID: 28098886
    [Abstract] [Full Text] [Related]

  • 13. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells.
    Shemesh CS, Hardy CW, Yu DS, Fernandez B, Zhang H.
    Photodiagnosis Photodyn Ther; 2014 Jun 16; 11(2):193-203. PubMed ID: 24657627
    [Abstract] [Full Text] [Related]

  • 14. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
    Banerjee SM, Acedo P, El Sheikh S, Harati R, Meecham A, Williams NR, Gerard G, Keshtgar MRS, MacRobert AJ, Hamoudi R.
    Front Immunol; 2023 Jun 16; 14():1188087. PubMed ID: 38022682
    [Abstract] [Full Text] [Related]

  • 15. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
    Broekgaarden M, de Kroon AI, Gulik TM, Heger M.
    Curr Med Chem; 2014 Jun 16; 21(3):377-91. PubMed ID: 23931271
    [Abstract] [Full Text] [Related]

  • 16. Photodynamic therapy of hepatocellular carcinoma using tetra-triethyleneoxysulfonyl zinc phthalocyanine as photosensitizer.
    Ogbodu RO, Nitzsche B, Ma A, Atilla D, Gürek AG, Höpfner M.
    J Photochem Photobiol B; 2020 Jul 16; 208():111915. PubMed ID: 32480203
    [Abstract] [Full Text] [Related]

  • 17. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
    Huang L, Wei G, Sun X, Jiang Y, Huang Z, Huang Y, Shen Y, Xu X, Liao Y, Zhao C.
    Eur J Med Chem; 2018 May 10; 151():294-303. PubMed ID: 29627724
    [Abstract] [Full Text] [Related]

  • 18. Novel piperazine-substituted silicon phthalocyanines exert anti-cancer effects against breast cancer cells.
    Nalçaoğlu A, Sarı C, Değirmencioğlu İ, Eyüpoğlu FC.
    Photodiagnosis Photodyn Ther; 2022 Mar 10; 37():102734. PubMed ID: 35066132
    [Abstract] [Full Text] [Related]

  • 19. Co-encapsulation of sodium diethyldithiocarbamate (DETC) and zinc phthalocyanine (ZnPc) in liposomes promotes increases phototoxic activity against (MDA-MB 231) human breast cancer cells.
    Feuser PE, Cordeiro AP, de Bem Silveira G, Borges Corrêa MEA, Lock Silveira PC, Sayer C, de Araújo PHH, Machado-de-Ávila RA, Dal Bó AG.
    Colloids Surf B Biointerfaces; 2021 Jan 10; 197():111434. PubMed ID: 33166932
    [Abstract] [Full Text] [Related]

  • 20. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P, Yang X, Kraus D, Jones P, Myers KA, Chen B.
    Sci Rep; 2015 Aug 18; 5():13298. PubMed ID: 26282350
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.